Article

Exploration and Identification of Potential Therapeutic Targets and Biomarkers for Docetaxel Resistant Prostate Cancer

2022-07-26

Abstract excerpt

<h4>Background: </h4> Prostate cancer has become the third most common cancer, and the death rate of advanced patients due to metastasis and invasion is high. Approximately 40–50% of castration resistant prostate cancer responding to docetaxel did not show a substantial and sustained prostate specific antigen decline, and the median response duration was limited to 6 to 9 months. To understand the pathogenesis of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 292ea888-18d2-5b3a-8fc4-b7c0dac7b52a
DOI: 10.21203/rs.3.rs-1172051/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exploration and Identification of Potential Therapeutic Targets and Biomarkers for Docetaxel Resistant Prostate CancerDOI 10.21203/rs.3.rs-1172051/v2Read

Identification and Validation of Four Novel Biomarkers Involved in Docetaxel Resistant Prostate CancerSemantic proximity Read

Identification of Key Genes and Molecular Mechanisms Associated With Docetaxel Resistance in Castration Resistant Prostate Cancer Based on Bioinformatics AnalysisSemantic proximity Read

Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAsSemantic proximity Read

Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate CancerSemantic proximity Read

An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancerSemantic proximity Read

Disulfidptosis-related genes serve as potential prognostic biomarkers and indicate tumor microenvironment characteristics and immunotherapy response in prostate cancerSemantic proximity Read

Progress in the mechanism and drug development of castration-resistant prostate cancer.Semantic proximity Read

Identification of genes required for enzalutamide resistance in castration-resistant prostate cancer cells <i>in vitro</i>Semantic proximity Read

Molecular mechanisms of docetaxel resistance in prostate cancerSemantic proximity Read

Prostate cancer cell-derived exosomes ZNF667-AS1 reduces TGFBR1 mRNA stability to inhibit Treg expansion and DTX resistance by binding to U2AF1Semantic proximity Read

Construct lactylation-related gene signature to effectively predict the disease-free survival and treatment responsiveness in prostate cancer based on the machine learningSemantic proximity Read

Exploration of the influence of GOLGA8B on prostate cancer progression and resistance of castration-resistant prostate cancer to cabazitaxelSemantic proximity Read